Global Cholesterol Test Market Overview
As per MRFR analysis, the Cholesterol Test Market Size was estimated at 7.26 (USD Billion) in 2024. The Cholesterol Test Market Industry is expected to grow from 7.86 (USD Billion) in 2025 to 16.14 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 8.32% during the forecast period (2025 - 2034). The growing prevalence of high cholesterol levels is expected to drive the growth. Rising awareness about a routine screening of cholesterol levels is another significant growth driver. These are just a few of the market drivers that are driving the market.Â
Source Secondary Research, Primary Research, Market Research Future Database and Analyst Review
Cholesterol Test Market Trends
Prevalence of cardiovascular diseases and rising cases of obesity propel market growth
The prevalence of cardiovascular diseases and rising cases of obesity are significantly driving market growth. Moreover, the inelastic need is related to cardiovascular patients requiring daily monitoring of Cholesterol for effective therapeutic monitoring. The health departments of various countries stipulate that children aged 9-11 should be tested, and young adults aged 17-21 should be tested. Cholesterol testing is critical to keeping patients on track with their health, as high Cholesterol shows no symptoms. Cholesterol testing involves estimating different lipids, such as triglycerides, HDL, LDL, and total blood cholesterol. If performed effectively with proper precautions at each stage, these tests can help reduce the risk of heart attack, peripheral arterial disease, and heart disease. Thus, this factor is driving the market CAGR.
Increasing numbers of heart attacks, diabetes, kidney failure and heart attacks have affected millions worldwide. Rising R&D investments and the development of new advanced testing procedures, supported by technological advancements in healthcare infrastructure in developing countries, have increased the demand for these tests. Advances in healthcare infrastructure have facilitated a high level of efficiency in diagnostic and Cholesterol management procedures. Furthermore, the rising adoption of AI and IoT in healthcare helps boost the market over the forecast period. Thus, it is anticipated that this aspect will accelerate the Cholesterol Test market revenue globally.
Cholesterol Test Market Segment Insights
Cholesterol Test Product Type Insights
Based on product type, the market segments of cholesterol test includes test kits and test strips. The test kits held the majority share in 2022 in the Cholesterol Test market data. Patients now have better access to cholesterol testing thanks to the development of cutting-edge testing kits. Due to technological advancements, cholesterol testing kits are expected to be the fastest-growing segment.
Cholesterol Test Test Type Insights
Based on test type, the Cholesterol Test market segmentation includes total cholesterol test, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) and Cholesterol and triglycerides/VLDL cholesterol test. The total cholesterol test dominated the market growth in 2022 and is projected to be the faster-growing segment during the forecast period, 2023-2034. This is attributed to an increased awareness of routine cholesterol testing and treatment and the sedentary lifestyle that contributes to the development of many diseases, including diabetes, which drives the market's growth.
Cholesterol Test Distribution Channel Insights
The market data of cholesterol test, based on the distribution channel, include over-the-counter and Prescription based. The target audience prefers all these distribution channels according to the consumer's requirements.
Cholesterol Test End-User Insights
Based on end-user, the market data of Cholesterol Test include hospitals & clinics, home care and diagnostic centers. The diagnostic center segment dominated the market revenue of Cholesterol Test in 2022 and is projected to be the faster-growing segment during the forecast period 2023-2034. Since more and more people are being diagnosed with high total Cholesterol, the demand for the market is rising. Moreover, regular health check-ups without physician intervention are a high-impact driver for the segment's growth.
Figure 1 Â Cholesterol Test Market by End-User, 2022 & 2034 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
Cholesterol Test Regional Insights
By region, the study provides market insights into North America, Europe, Asia-Pacific and the Rest of the World. The North America Cholesterol Test market accounted for USD 2.8 billion in 2022, with a share of around 45.80%, and is expected to exhibit a significant CAGR growth during the study period. Americas is the most important regional market. Countries like the US have well-developed healthcare operations. Furthermore, one of the major reasons driving the cholesterol testing market during the forecast years is the rising prevalence of stroke in the United States.
Further, the major countries studied in the market report are The U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2 Â CHOLESTEROL TEST MARKET SHARE BY REGION 2022 (%)
Source Secondary Research, Primary Research, Market Research Future Database and Analyst Review
Europe's Cholesterol Test market accounts for the second-largest market share. Rising awareness among patients regarding preventive healthcare has increased the usage of cholesterol-testing products and services. Potential players in the market have helped increase market efficiency and production of these test kits and devices, further increasing the market opportunity. Moreover, the UK market of cholesterol test held the largest market share, and the Germany market of cholesterol test was the fastest-growing market in the region.
Asia Pacific Cholesterol Test Market is expected to grow at the fastest CAGR from 2023 to 2034. Asia Pacific is growing faster and more lucrative owing to the increasing population in the region. An increase in investment and expenditure in healthcare infrastructure has led to the development of diagnostic centers and pathology laboratories for better diagnosis. Further, the China market of cholesterol test held the largest market share, and the India market of cholesterol test was the fastest-growing market in the region.
Cholesterol Test Key Market Players & Competitive Insights
Major market players are spending a lot on R&D to increase their product lines, which will help the market of Cholesterol Test grow even more. Market participants are also taking various strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, mergers and acquisitions, contractual agreements, increased investments, and collaboration with other organizations. Competitors in the Cholesterol Test industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.
One of the primary business strategies manufacturers adopt in the Cholesterol Test industry to benefit clients and expand the market sector is manufacturing locally to reduce operating costs. The Cholesterol Test industry has provided medicine with some of the most significant benefits in recent years. The Cholesterol Test market players such as Nestle, JM Smucker Company, The Kraft Heinz Company and Starbucks Cholesterol Test Company.
Quest Diagnostics empowers people to take action to improve health outcomes. Quest's diagnostic insights, drawn from the world's largest database of clinical laboratory results, reveal new ways to identify and treat disease, inspire healthy behaviors, and improve healthcare management. In June 2022, Quest Diagnostics, the world's leading provider of diagnostic information services, announced that it would hold its 82nd. The results of six studies were presented at the American Diabetes Association Scientific Sessions in New Orleans, LA.
Also, Thermo Fisher Scientific Inc. is an American provider of scientific instruments, reagents and consumables, and software services. Thermo Fisher, headquartered in Waltham, Massachusetts, was formed in 2006 through the merger of Thermo Electron and Fisher Scientific. Thermo Fisher Scientific has acquired other reagents, consumables, instrumentation and service providers, including Life Technologies Corporation (2013), Affymetrix (2015), Affymetrix (2016), FEI Corporation (2016), BD Advanced Bioprocessing (2018), PPD (2021).
Key Companies in the market of Cholesterol Tests include
- Quest Diagnostics Incorporated
- Clinical Reference Laboratory Inc.
- Randox Laboratories Ltd.
- PTS DIAGNOSTICS
- Hoffmann-La Roche AG
- Cell Biolabs Inc.
- Laboratory Corporation of America Holdings
- Thermo Fisher Scientific
- Alere Inc.
- Eurofins Scientific
Cholesterol Test Market Developments
-
Q2 2024: Abbott Launches Next-Generation Cholesterol Test System in the U.S. Abbott announced the commercial launch of its new Alinity cholesterol testing system, designed to deliver faster and more accurate lipid panel results for clinical laboratories across the United States.
-
Q1 2024: Roche Receives FDA Clearance for Cobas Lipid Panel Test Roche announced it has received U.S. FDA clearance for its Cobas Lipid Panel, a new cholesterol and triglyceride test for use on its Cobas analyzers, expanding its diagnostic portfolio in the cardiovascular space.
-
Q2 2024: Quest Diagnostics Expands Direct-to-Consumer Cholesterol Testing Service Quest Diagnostics launched a new direct-to-consumer cholesterol test kit, allowing individuals to order and perform cholesterol tests at home, with results delivered digitally.
-
Q3 2024: Siemens Healthineers Partners with CVS Health to Offer In-Store Cholesterol Testing Siemens Healthineers announced a partnership with CVS Health to provide point-of-care cholesterol testing in select CVS Pharmacy locations nationwide, aiming to improve access to preventive cardiovascular screening.
-
Q2 2024: Startup CardioCheck Raises $25 Million to Scale At-Home Cholesterol Monitoring Device CardioCheck, a health tech startup, closed a $25 million Series B funding round to accelerate the commercialization of its FDA-cleared at-home cholesterol monitoring device.
-
Q1 2025: Bio-Rad Laboratories Acquires LipidSense Diagnostics for $120 Million Bio-Rad Laboratories announced the acquisition of LipidSense Diagnostics, a company specializing in advanced cholesterol and lipid testing technologies, to strengthen its clinical diagnostics portfolio.
-
Q2 2025: FDA Approves Beckman Coulter’s New High-Sensitivity Cholesterol Assay Beckman Coulter received FDA approval for its high-sensitivity cholesterol assay, designed to improve the detection of cardiovascular risk in routine clinical practice.
-
Q1 2024: Eurofins Scientific Opens New Cholesterol Testing Laboratory in Texas Eurofins Scientific inaugurated a new state-of-the-art laboratory in Houston, Texas, dedicated to advanced cholesterol and lipid panel testing for clinical and research clients.
-
Q3 2024: Boston Heart Diagnostics Launches AI-Powered Cholesterol Risk Assessment Tool Boston Heart Diagnostics introduced an AI-driven tool that integrates cholesterol test results with patient data to provide personalized cardiovascular risk assessments for clinicians.
-
Q2 2025: Roche Launches Next-Generation Point-of-Care Cholesterol Test in Europe Roche announced the European launch of its new point-of-care cholesterol testing device, enabling rapid lipid panel results in primary care and pharmacy settings.
-
Q1 2025: Sigma-Aldrich Unveils New Reagent Kit for Automated Cholesterol Testing Sigma-Aldrich released a new reagent kit compatible with major automated analyzers, designed to streamline cholesterol testing workflows in clinical laboratories.
-
Q3 2025: Beckman Coulter Signs Multi-Year Supply Agreement with Major U.S. Health System for Cholesterol Testing Solutions Beckman Coulter entered into a multi-year contract to supply its cholesterol testing platforms and reagents to one of the largest health systems in the United States, expanding its footprint in hospital diagnostics.
Cholesterol Test Market Segmentation
Cholesterol Test Product Type Outlook (USD Billion, 2018-2030)
Cholesterol Test Test Type Outlook (USD Billion, 2018-2030)
- Total Cholesterol Test
- High-Density Lipoprotein (HDL) Cholesterol
- Low-Density Lipoprotein (LDL)
- Cholesterol and Triglycerides/VLDL Cholesterol Test)
Cholesterol Test Distribution Channel Outlook (USD Billion, 2018-2030)
- Over the Counter
- Prescription Based
Cholesterol Test End-User Outlook (USD Billion, 2018-2030)
- Hospitals & Clinics
- Homecare
- Diagnostic Centers
Cholesterol Test Regional Outlook (USD Billion, 2018-2030)
| Report Attribute/Metric |
Details |
| Market Size 2024 |
  7.26 (USD Billion) |
| Market Size 2025 |
  7.86 (USD Billion) |
| Market Size 2034 |
 16.14 (USD Billion) |
| Compound Annual Growth Rate (CAGR) |
  8.32 % (2025 - 2034) |
| Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year |
2024 |
| Market Forecast Period |
2025 - 2034 |
| Historical Data |
2020 - 2024 |
| Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
Product Type, Test Type, Distribution Channel, End User, and Region |
| Geographies Covered |
North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered |
The U.S, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled |
Nestle, JM Smucker Company, The Kraft Heinz Company and Starbucks Cholesterol Test Company |
| Key Market Opportunities |
High growth potential in emerging economies. |
| Key Market Dynamics |
Increasing incidence of cardiovascular diseases and obesity Physician’s preference for lab testing over self-testing |
Cholesterol Test Market Highlights:
Frequently Asked Questions (FAQ):
The cholesterol test market size was valued at USD 6.2 Billion in 2022.
The market is projected to grow at a CAGR of 8.32% from 2034.
North America had the largest share of the market
The key players in the market are quest diagnostics incorporated, clinical reference laboratory inc., randox laboratories ltd., PTS diagnostics, and Hoffman-La Roche, an ag cholesterol test company.
The test kits dominated the market in 2022.
Hospitals & clinics had the largest share of the market.
